Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Jul 29;4(11):1835–1841. doi: 10.1158/1940-6207.CAPR-11-0146

Table 3.

Frequency-dosage measure of aspirin use and odds ratios for pancreatic cancer

Aspirin use Controls Cases OR* (95% CI) P value
Tablets per month (mean, SD) 13.5 ± 22.1 10.9 ± 18.2 0.990 (0.985-0.996) 0.002
Frequency-dosage measure of
aspirin use (counts, %)
n (%) n (%)
  Non-users 270 (27.6) 235 (33.7) 1.00 0.022
  Light dose- infrequent use 350 (35.8) 242 (34.7) 0.89 (0.69-1.02)
  Heavy dose- infrequent use 123 (12.6) 75 (10.8) 0.74 (0.51-1.08)
  Light dose- frequent use 186 (19.0) 120 (17.2) 0.65 (0.47-0.91)
  Heavy dose- frequent use 49 (5.0) 25 (3.6) 0.52 (0.28-0.95)
*

adjusted for age, sex, body mass index (continuous), smoking status (never, former, current), pack years of smoking and long standing diabetes mellitus (> 3 years)